Wells Fargo & Company Trans Medics Group, Inc. Call Options Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
Call Options
2 transactions
Others Institutions Holding TMDX
# of Institutions
290Shares Held
28.9MCall Options Held
338KPut Options Held
370K-
Black Rock Inc. New York, NY2.52MShares$355 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.89MShares$265 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C31.3MShares$182 Million0.11% of portfolio
-
Driehaus Capital Management LLC Chicago, IL1.28MShares$180 Million1.04% of portfolio
-
Invesco Ltd. Atlanta, GA1.28MShares$180 Million0.02% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $4.47B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...